EWP
ABVX icon

Elevation Wealth Partners’s Abivax ABVX Stock Holding History

Elevation Wealth Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.67K Hold
27
– – ﹤0.01% 1206
2026
Q2 		$3.6K Buy
+27
New +$3.06K ﹤0.01% 1094

Other funds holding ABVX

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Elevation Wealth Partners's ABVX Position: Q3 2026 in Review

Elevation Wealth Partners held its Abivax (ABVX) position steady in Q3 2026 at 27 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.

Elevation Wealth Partners first reported a position in ABVX in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.6K in Q2 2026. 9 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Elevation Wealth Partners held 27 shares of Abivax worth $2.67K as of Q3 2026.
  • Elevation Wealth Partners left its Abivax share count unchanged in Q3 2026.
  • Abivax made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1206 holding.
  • Elevation Wealth Partners first reported a position in Abivax in Q2 2026 and has held it in 2 quarters since.
  • Elevation Wealth Partners's Abivax position peaked at $3.6K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.